RecallWatchUSA

Home / Categories / Drugs

Drugs Recalls

17,897 recalls, newest first.

February 2, 2022DrugsFDA
Edge Pharma, LLC recalls Cantharidin PLUS, Cantharidin/Salicylic Acid Gel-Forming Suspension, 10 mL per vial, Multiple Dose Vials for Topical Use
Hazard: CGMP Deviations
February 2, 2022DrugsFDA
Edge Pharma, LLC recalls Cantharidin Gel-Forming Suspension, 0.7%, 10 mL per vial, Multiple Dose Vial for Topical Use, Edge Pharma, LLC, 856 Herc
Hazard: CGMP Deviations
February 2, 2022DrugsFDA
Edge Pharma, LLC recalls BLT Topical Cream, Benzocaine/Lidocaine/Tetracaine, 20%/8%/4%, 60gm per jar, Multiple Dose Container For Topical Use, Ed
Hazard: CGMP Deviations
February 2, 2022DrugsFDA
Edge Pharma, LLC recalls Vancomycin HCl in 0.9% Sodium Chloride Injection, USP, 1,750mg/500mL, Single Use Bag for IV Injection (Preservative Free
Hazard: Lack of Assurance of Sterility
February 2, 2022DrugsFDA
Edge Pharma, LLC recalls Vancomycin HCl in 0.9% Sodium Chloride Injection, 1,500 mg/500 mL, USP, Single Use Bag for IV Injection (Preservative Fr
Hazard: Lack of Assurance of Sterility
February 2, 2022DrugsFDA
Edge Pharma, LLC recalls Vancomycin HCl in 0.9 % Sodium Chloride Injection, USP, 1,250 mg/250 mL, Single Use Bag for IV Injection (Preservative F
Hazard: Lack of Assurance of Sterility
February 2, 2022DrugsFDA
Edge Pharma, LLC recalls Vancomycin HCl, Sterile Ophthalmic Solution for Injection, Preservative Free, 8 mg/0.8mL (10 mg/mL) (vancomycin equivale
Hazard: Lack of Assurance of Sterility
February 2, 2022DrugsFDA
Edge Pharma, LLC recalls Betadine (povidone-iodine), Sterile Ophthalmic Solution, Preservative Free, 5% 0.5mL per syringe, Single Use Syringe, Fo
Hazard: Lack of Assurance of Sterility
February 2, 2022DrugsFDA
Edge Pharma, LLC recalls Phenylephrine HCl/Tropicamide/Cyclopentolate HCl/ Ketorolac Sterile Ophthalmic Solution, 10%/ 0.25%/ 0.25%/0.125%, 10 mL
Hazard: Lack of Assurance of Sterility
February 2, 2022DrugsFDA
Edge Pharma, LLC recalls Phenylephrine HCl/Tropicamide/Cyclopentolate HCl/Ketorolac Sterile Ophthalmic Solution, 2.5%/0.25%/0.25%/0.125%, 0.5 mL
Hazard: Lack of Assurance of Sterility
February 2, 2022DrugsFDA
Edge Pharma, LLC recalls Phenylephrine HCl/Tropicamide, Sterile Ophthalmic Solution, 2.5%/1%, 15 mL per dropper, Multiple Dose Droptainer for Top
Hazard: Lack of Assurance of Sterility
February 2, 2022DrugsFDA
Edge Pharma, LLC recalls Phenylephrine HCl/Lidocaine, Sterile Ophthalmic Solution for Injection, Preservative Free, 1.5%/1%, 0.8mL per syringe, S
Hazard: Lack of Assurance of Sterility
February 2, 2022DrugsFDA
Edge Pharma, LLC recalls PHENYLephrine, 0.9% Sodium Chloride Injection, USP, 20 mg/250mL, (0.08 mg/mL), Single use bag for IV injection (Preserva
Hazard: Lack of Assurance of Sterility
February 2, 2022DrugsFDA
Edge Pharma, LLC recalls Phenylephrine HCl, Sterile Solution for Injection, (PF), 800 mcg/10mL (80 mcg/mL), Single Use Syringe for IV Injection,
Hazard: Lack of Assurance of Sterility
February 2, 2022DrugsFDA
Edge Pharma, LLC recalls Phenylephrine HCl, 1mg/10mL (0.1mg/mL), 10 mL per syringe, Single Use Syringe for IV Injection, Edge Pharma, LLC, 856 He
Hazard: Lack of Assurance of Sterility
February 2, 2022DrugsFDA
Edge Pharma, LLC recalls Phenylephrine HCl 0.5 mg/5mL, (0.1 mg/mL), 5 mL per syringe, Single Use Syringe for IV Injection, Edge Pharma, LLC, 856
Hazard: Lack of Assurance of Sterility
February 2, 2022DrugsFDA
Edge Pharma, LLC recalls Phenylephrine HCl / Tropicamide / Ciprofloxcin / Ketorolac Sterile Ophthalmic Solution, 10%/1%/0.3%/0.125%, 0.8 mL per s
Hazard: Lack of Assurance of Sterility
February 2, 2022DrugsFDA
Edge Pharma, LLC recalls Phenol, Sterile Solution for Injection (PF), 6%, 5 mL per vial, Single Use Vial for Perineural Injection, Edge Pharma, L
Hazard: Lack of Assurance of Sterility
February 2, 2022DrugsFDA
Edge Pharma, LLC recalls MVASI, (bevacizumab-awwb), Sterile Ophthalmic Solution for Injection, 3.25mg/0.13mL (25 mg/mL) 0.13 mL per syringe, Dose
Hazard: Lack of Assurance of Sterility
February 2, 2022DrugsFDA
Edge Pharma, LLC recalls Neostigmine methylsulfate, 5 mg/5mL (1 mg/mL), 5 mL per syringe, Single Use Syringe for IV or IM Injection, Edge Pharma,
Hazard: Lack of Assurance of Sterility
February 2, 2022DrugsFDA
Edge Pharma, LLC recalls Moxifloxacin, Sterile Ophthalmic Solution for Injection, Preservative Free, 0.8mg/0.8 mL (1mg/mL), 0.8 mL per syringe, S
Hazard: Lack of Assurance of Sterility
February 2, 2022DrugsFDA
Edge Pharma, LLC recalls Mitomycin-C, Sterile Ophthalmic Solution, Preservative Free, 0.16mg/0.8mL (0.2 mg/mL), 0.8 mL per syringe, Single Use Sy
Hazard: Lack of Assurance of Sterility
February 2, 2022DrugsFDA
Edge Pharma, LLC recalls Mitomycin-C Sterile Ophthalmic Solution, Preservative Free, 0.32mg/0.8 mL (0.4mg/mL) 0.8 mL per syringe, Single Use Syri
Hazard: Lack of Assurance of Sterility
February 2, 2022DrugsFDA
Edge Pharma, LLC recalls Mitomycin-C, 40mg/40mL (1mg/mL), 40 mL per syringe, Single Dose Syringe for Intravesical Use, Edge Pharma, LLC, 856 Herc
Hazard: Lack of Assurance of Sterility
February 2, 2022DrugsFDA
Edge Pharma, LLC recalls Methotrexate, USP, Sterile Solution for Injection (PF), 125 mg/5mL (2mg/mL), 5 mL per syringe, Edge Pharma, LLC, 856 Her
Hazard: Lack of Assurance of Sterility
February 2, 2022DrugsFDA
Edge Pharma, LLC recalls Methacholine Challenge 5-Syringe Test Kit, Sterile Inhalation Solution, Preservative Free, 3 mL per syringe,(NDC 05446-
Hazard: Lack of Assurance of Sterility
February 2, 2022DrugsFDA
Edge Pharma, LLC recalls Lidocaine HCL / Bupivacaine HCL (contains Hyaluronidase 15 units/mL), Sterile Ophthalmic Solution for Injection (PF), 2%
Hazard: Lack of Assurance of Sterility
February 2, 2022DrugsFDA
Edge Pharma, LLC recalls Gemcitabine, Sterile Intravesical Solution, Preservative Free, 1g/50mL (20 mg/mL), 50 mL per syringe, Single Dose Syring
Hazard: Lack of Assurance of Sterility
February 2, 2022DrugsFDA
Edge Pharma, LLC recalls Epinephrine/Lidocaine HCl Sterile Ophthalmic Solution for Injection, Preservative Free, 0.025%/0.75%, 0.8 mL per syringe
Hazard: Lack of Assurance of Sterility
February 2, 2022DrugsFDA
Edge Pharma, LLC recalls Edetate Disodium (EDTA), Sterile Ophthalmic Solution, (PF) 3%, 10mL per dropper, Single Dose Droptainer for Topical Opht
Hazard: Lack of Assurance of Sterility